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Abstract. In a study of children having polyparasitic infections in a Schistosoma haematobium–endemic area, we
examined the hypothesis that S. haematobium–positive children, compared with S. haematobium–negative children (anti-
soluble worm antigen preparation [SWAP] negative and egg negative) have increased systemic production of pro-
inflammatory cytokines (interleukin [IL]-6, tumor necrosis factor [TNF]-a) and decreased down-regulatory IL-10. A total
of 804 children, 2–19 years of age, were surveyed between July and December 2009 and tested for S. haematobium,
Plasmodium falciparum, filariasis, and soil-transmitted helminth infections. Plasma levels of IL-6, TNF-a, and IL-10
were compared for S. haematobium–positive and S. haematobium–negative children, adjusting for malaria, filaria, and
hookworm co-infections, and for nutritional status, age group, sex, and geographic location. IL-10 was significantly
elevated among children infected with S. haematobium, showing bimodal peaks in 7–8 and 13–14 years age groups. IL-
10 was also higher among children who were acutely malnourished, whereas IL-10 levels were lower in the presence of
S. haematobium–filaria co-infection. After adjustment for co-factors, IL-6 was significantly elevated among children of 5–
6 years and among those with P. falciparum infection. Lower levels of IL-6 were found in malaria–hookworm co-infection.
High levels of TNF-a were found in children aged 11–12 years regardless of infection status. In addition, village of residence
was a strong predictor of IL-6 and IL-10 plasma levels. In adolescent children infected with S. haematobium, there is an
associated elevation in circulating IL-10 that may reduce the risk of later morbidity. Although we did not find a direct link
between S. haematobium infection and circulating pro-inflammatory IL-6 and TNF-a levels, future T-cell stimulation
studies may provide more conclusive linkages between infection and cytokine responses in settings that are endemic for
multiple parasites and multiple co-infections.
INTRODUCTION
Data are scarce regarding the immune responses of children
affected by chronic schistosomiasis and other overlapping par-
asitic infections, including malaria, filaria, and soil-transmitted
helminth infections, experienced either sequentially or as
polyparasitic disease. With an estimated 230 million people
affected by schistosomiasis, and almost half of them being
children,1 there remains a significant knowledge gap regarding
the timing and mechanisms for the initiation of Schistosoma-
associated morbidity. As a result, schistosomiasis treatment
campaigns may not be targeting an appropriate age range to
prevent advanced disease due to end-organ fibrosis.2
Laboratory and clinical studies suggest that adaptive host
immune responses can modulate manifestations of schistoso-
miasis morbidity.3 However, production of pro-inflammatory
cytokines is an essential part of chronic Schistosoma infection,
and have been associated with malnutrition and anemia of
inflammation, for example, by IL-6 stimulation of hepcidin
production, a liver hormone responsible for sequestration of
iron.4–6 In S. japonicum–endemic settings, end-organ damage,
manifesting as liver fibrosis, has been associated with elevated
pro-inflammatory cytokine responses highlighting the correla-
tion between inflammation and fibrosis.5,7 Less is known about
the link between S. haematobium–related cytokine response
and infection-associated morbidity.8
The exact timing of the organ damage is largely unknown.
Therefore, by analyzing the age profile of circulating pro-
inflammatory (IL-6 and TNF-a) and immunomodulatory
(IL-10) cytokines in the presence and absence of active
S. haematobium infection, we aimed to identify the onset of
inflammation and adaptive downregulation in chronically
exposed children. To do this, we used a refined definition of
S. haematobium infection that included either anti-parasite
antibody positivity or egg patent infection. Our second objec-
tive was to correlate these cytokine levels with the presence or
absence of schistosomiasis-associated morbidities such as
anemia and undernutrition, and to explore interactions related
to concurrent co-infections.
METHODS
Children aged 2–19 years (N = 804) were surveyed between
July and December 2009 from two S. haematobium–endemic
villages in Matuga and Msambweni sub-counties (in former
Coast Province), Kenya (Figure 1) as detailed elsewhere.9
The selected villages included low S. haematobium prevalence
Vuga, and high prevalence Milalani (Table 1). Briefly,
data collection included demography, urine filtration for
S. haematobium eggs (one urine),10 and Kato-Katz11 stool
examination for soil-transmitted helminths (one stool). Blood
collection was performed by finger prick for the rapid antigen
detection of P. falciparum (ICTDiagnostics, Sydney, Australia)
and Wuchereria bancrofti filarial infection (Binax, Portland,
ME).9 After centrifugation, plasma samples were kept frozen
at −80°C.
Hemoglobin was determined (Hemocue, A˚ngelholm,
Sweden), and anemia and severe anemia were categorized
according to World Health Organization (WHO) criteria for
age and sex, and scored as present or absent for each child.12
Reference population Z scores were calculated for each sub-
ject’s height-for-age (HAZ) and body mass index-for-age
*Address correspondence to Amaya L. Bustinduy, Pembroke Place,
Liverpool, L3 5QA, United Kingdom. E-mails: Amaya.Bustinduy@
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(BAZ) using international standards for comparison, taken
from the WHO’s Anthro program for ages 0–5 years and
WHO Anthro-plus program for ages 5–19 years (WHO,
Geneva, Switzerland).13 According to WHO standards,
stunting was categorized as an observed HAZ that was two
or more standard deviations (SDs) below average (HAZ
score < −2). Children were categorized as clinically wasted if
their BAZ was more than 2 SDs below average for their age
(BAZ score < −2).13
Ethical clearance was obtained from the Institutional
Review Board at Case Western Reserve University and the
Ethical Review Committee at the Kenya Medical Research
Institute (KEMRI). Informed consent was obtained from
each child’s parent or guardian and verbal assent was
obtained from children above 7 years of age. All infections
detected during this study were treated in accordance with the
national guidelines of Kenyan Ministry of Medical Services.
Ultimately, 790 children provided full clinical and laboratory
data (see Figure 2 for flow chart of enrollment), and these
subjects with complete data were included in the data analysis
presented in this article.
Anti-Schistosoma IgG4 antibody detection assay. To
increase sensitivity for the detection of early, possibly egg-
negative S. haematobium infection among younger children,
we performed serologic testing for circulating anti-parasite
IgG4 in all study subjects. Soluble worm antigen preparation
(SWAP) (crude extract) was provided courtesy of Christopher
King, Center for Global Health and Diseases, Cleveland,
OH. Ninety-six-well plates were coated with 50 mL of 10 mg/
mL SWAP diluted in enzyme-linked immunosorbent assay
(ELISA) coating buffer and allowed to incubate at 4°C over-
night. The plates were then blocked with ELISA blocking
buffer and washed with ELISA wash buffer as described pre-
viously.14 Serum samples prepared in ELISA diluent buffer
were then allowed to incubate on the antigen-coated plate at
4°C overnight.14 The plates were washed six times and incu-
bated with 50 mL of a 1:2,000 dilution of mouse anti-human
IgG4 (Jackson ImmunoResearch,West Grove, PA) for 2 hours.
Plates were then washed and incubated with 50 mL of 1:1,000
dilution of goat anti-mouse, alkaline phosphatase–conjugated
Figure 1. Map of the study villages in Kwale County, Kenya.
Table 1
Population characteristics and cytokine distribution by village
Milalani (N = 191) Vuga (N = 613)
Demography
Mean age ± SD in years (range) 12.4 ± 3.2 (5–19) 11.0 ± 3.7 (2–18)*
Female sex, n (%) 96 (50) 313 (51)
Morbidity
Mean hemoglobin ± SD (range) 11.8 ± 1.9 (4.6–16.4) 11.8 ± 1.4 (6.1–15.9)
Anemia, n (%) 90 (47) 251 (41)
Stunting (HAZ < −2) 61 (32%) 263 (43%)*
Wasting (BAZ < −2) 21 (11%) 188 (31%)*
Parasitic infections
Schistosoma haematobium
Mean egg count 127 (0–1,000) 54 (0–1,000)*
Any intensity positive, n (%) 130 (68) 155 (25)*
Light (< 50 eggs/10 mL urine) 62 (32%) 80 (13%)
Heavy (> 50 eggs/10 mL urine) 68 (36%) 75 (12%)
Anti-SWAP IgG4‡
Positive, n (%) 147 (77) 253 (41)*
Malaria (P. falciparum), n (%) 33 (17) 77 (13)
Filaria (W. bancrofti), n (%) 21 (11) 97 (16)
Hookworms, n (%) 43 (22) 64 (10)*
Cytokines
Median IL-6 pg/mL (range) 204 (2–165,586) 298 (4–9,033)†
Median IL-10 pg/mL (range) 180 (1–2,473) 353 (2–424,996)†
Median TNF-a pg/mL (range) 102 (7–769) 104 (2–7,916)
SD = standard deviation; HAZ = age-adjusted height Z-score; BAZ, age-adjusted body-mass index Z-score; IL = interleukin; TNF = tumor necrosis factor.
*P < 0.01, significant difference between villages: c2 test for categorical variables, Student’s t test for continuous variables.
†P < 0.001 for significant difference between villages, nonparametric testing by Mann–Whitney U test.
‡Antibody against Schistosoma adult Soluble Worm Antigen.
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antibody (Jackson ImmunoResearch) for 1 hour. The plates
were washed and incubated with alkaline phosphatase sub-
strate in buffer (Sigma Aldrich, St. Louis, MO) for 15 minutes.
After 15 minutes, the reaction was stopped with 50 mL of 5%
EDTA. Bound IgG4 was then measured by the determination
of optical density at 415 nm. The cutoff for a positive test was
set at 2 SDs above the mean optical density of 20 negative
control sera obtained from an area in northern Kenya
endemic for multiple parasites, but not endemic for schistoso-
miasis or filariasis (courtesy Christopher King Laboratory,
CWRU, Cleveland, OH).
Circulating cytokine detection and quantification assays.
Ninety-six-well Immulon IV ELISA plates were coated with
50 mL of 2.5 mg/mL primary antibody against IL-10, IL-6, and
TNF-a (BD Diagnostics, San Jose, CA) diluted in ELISA
coating buffer and allowed to incubate at 4°C overnight.
After further washing and blocking of the plates, subject sam-
ples with standards and blanks were added in a 1:2 dilution
and allowed to incubate at 4°C overnight. The plates were
then washed and respective detection (biotinylated) antibod-
ies were added, and the plates were incubated at room tem-
perature for 45 minutes. The plates were rewashed and
incubated in the presence of streptavidin alkaline phosphate
for 30 minutes. The plates were then washed and incubated
with alkaline phosphatase substrate buffer (Sigma Aldrich)
for 1 hour. After 15 minutes, the reaction was stopped with
50 mL of 5%EDTA. Bound cytokines (IL-10, IL-6, and TNF-a)
were then measured by the determination of optical density
at 415 nm. There was a standard ELISA curve for each
plate from the positive control standards, and the individual
subject plasma levels (in pg/mL) were then interpolated from
that curve.
Data entry and statistical analysis. All data were entered in
Microsoft Excel (Redmond, King County, WA) and analyzed
using the R statistical package version 2.14.1 (The R Founda-
tion for Statistical Computing, Vienna, Austria) and SPSS
v.21 software (IBM Corp., Armonk, NY). Arithmetic and
geometric mean (GMW) were calculated for S. haematobium
infection intensity. For percentages, 95% confidence intervals
(CI) were calculated by applying the exact method.
S. haematobium mean egg count, hookworm egg count, anti-
body values, and cytokine values were found to have a non–
Gaussian distribution and were compared using non-parametric
statistics, or were log transformed for multivariable linear
modeling. Categorical variables were created for malaria,
hookworm, anemia, S. haematobium intensity of infection,
wasting, and stunting. A case definition of schistosomiasis
was created with aggregated variables S. haematobium egg
and/or anti-SWAP positive. Analysis of variance (ANOVA)
or c2 testing was performed to assess the significance of dif-
ferences detected among the study villages. Initial exploratory
analysis included bivariate correlations between IL-6, IL-10,
TNF-a levels, and the different covariates of interest: infection
status, age, sex, village anemia, wasting, stunting, and other
cytokines. Concurrent cytokine level predictors were also
included in multivariable linear regression models.
RESULTS
Location-related differences. A total of 804 children were
surveyed from two villages (see Figure 1 and Table 1).
Milalani children were slightly older (mean age 12.4 versus
11.0, P < 0.01), but the male and female composition of the
two community survey samples was not significantly different
(Table 1). In high-prevalence Milalani (N = 191), 68% of the
children had egg-patent S. haematobium infection in contrast
to 25% of children in Vuga (N = 613). Schistosoma sero-
prevalence was again markedly higher in Milalani (77%) in
contrast to Vuga (41%). More high-intensity S. haematobium
infections (based on standardized urine filtration egg counts)
were present in Milalani and the mean egg count per subject
was higher in Milalani (Table 1). Other parasitic infections
including malaria, hookworm, and filariasis were found in
both villages (Table 1). Whereas levels of detected malaria
and filarial infection were not significantly different between
the two villages, hookworm was more common in Milalani
(22% prevalence versus 10% in Vuga, P < 0.01) (Table 1).
In terms of clinical morbidity, the prevalence of anemia was
not significantly different between the two villages: 47% in
Milalani versus 41% in Vuga. However, a significantly greater
proportion of children were malnourished in Vuga, with 43%
of them being stunted and 31% wasted, compared with 32%
and 11%, respectively, in Milalani.
For the cytokine outcomes measured, we observed overall
higher levels of pro-inflammatory IL-6 and down-regulatory
IL-10 among children from Vuga village as compared
with Milalani. Levels of TNF-a did not vary significantly
between locations.
Cytokine age-related distribution. The age-related distribu-
tion of the cytokines analyzed by infection status is shown in
Figure 3. After controlling for possible confounders (sex,
malaria, anemia, schistosomiasis, hookworm, wasting, stunting,
and other cytokines), age remained a significant independent
predictor of IL-6 response, with children aged 5–6 years having
higher levels of IL-6 (see Table 2). IL-10 levels were signifi-
cantly lower in children aged 11–12 years and 17–19 years as
Figure 2. Flow diagram with the design of the study.
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compared with 13–14 years when the model was adjusted for
possible confounders (see Table 3). TNF-a levels were signif-
icantly higher in 11- to 12-year-old children (see Table 4).
Cytokine levels and infection. Overall, median IL-6 levels
were higher (P = 0.008, Mann–Whitney U test), and IL-10
levels were also higher (P = 0.003), among children infected
with S. haematobium (antibody positive and/or egg positive)
when compared with those not infected by S. haematobium.
However, after adjustment for co-factors, the S. haematobium
effect on IL-6 was no longer significant (Table 2), whereas the
S. haematobium effect on IL-10 remained significant (Table 3).
Nevertheless, we observed that IL-6 was particularly elevated
among S. haematobium–infected children aged 11–12 years
Table 2
Multivariable log-linear modeling for the association of IL-6 with
potential explanatory variables
Variables
Multivariable model for log10-IL6 level
B coefficient 95% CI P value
IL-10* −0.018 (−0.079, 0.051) 0.673
TNF-a* 0.262 (0.201, 0.391) < 0.0001
Sex (male) 0.028 (−0.040, 0.094) 0.424
Village (Vuga) 0.131 (0.067, 0.240) 0.001
5–6 years old 0.091 (0.007, 0.269) 0.040
Wasted† −0.013 (−0.113, 0.084) 0.771
Stunted‡ 0.021 (−0.060, 0.102) 0.609
Malaria 0.112 (0.015,0.210) 0.024
S. haematobium§ 0.052 (−0.024,0.129) 0.180
Hookworm 0.029 (−0.070,0.127) 0.567
Malaria–hookworm −0.076 (−0.503, −0.011) 0.040
Final models adjusted for sex, age category, location, wasting, stunting, anemia, individual
infections (S. haematobium, malaria, hookworm), and any significant interactions for infec-
tion by two or more parasites.
*log10 of IL-10 and TNF-a.
†Wasting: Body mass index-for-age Z score (BAZ) < −2 SD.
‡Stunting: Height-for-age Z score (HAZ) < −2 SD.
§Positive infection status is defined by S. haematobium egg +/antibody +, egg –/antibody +,
or egg +/antibody –.
Table 3
Multivariable log-linear modeling for the association of IL-10 with
potential explanatory variables
Variables
Multivariable model for log10-IL-10 level
B coefficient 95% CI P value
TNF-a* 0.584 (0.773, 0.947) < 0.0001
IL-6* −0.013 (−0.094, 0.061) 0.673
Sex (male) 0.011 (−0.059, 0.087) 0.713
Village (Vuga) 0.123 (0.092, 0.281) < 0.0001
11–12 years −0.104 (−0.308, −0.057) 0.004
17–19 years old −0.121 (−0.468, −0.146) < 0.0001
Wasted† 0.107 (0.001, 0.214) 0.048
Stunted‡ −0.035 (−0.123, 0.054) 0.434
Malaria −0.083 (−0.189, 0.022) 0.121
S. haematobium§ 0.207 (−0.288, −0.126) < 0.0001
Hookworm 0.001 (−0.105, 0.107) 0.985
Schisto–Filaria −0.069 (−0.350, −0.033) 0.018
Final models adjusted for sex, age category, location, wasting, stunting, anemia, individual
infections (S. haematobium, malaria, hookworm), and significant interactions for infection by
two or more parasites.
* log10 of IL-6 and TNF-a.
†Wasting: Body mass index-for-age Z score (BAZ) < −2 SD.
‡Stunting: Height-for-age Z score (HAZ) < −2 SD.
§Positive infection status is defined by S. haematobium egg +/antibody +, egg –/antibody +,
or egg +/antibody –.
Figure 3. Age-related changes in cytokine levels according to S. haematobium infection status (Anti-SWAP positive and/or egg positive),
contrasted with age-group-specific intensity of infection.
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(compared with S. haematobium–negative children of the
same and other age groups), and IL-10 was highest among
S. haematobium–infected children in the 13- to 14-year age
group (compared with S. haematobium–uninfected children in
that and other age groups) (see Figure 2). We also noted that
11- to 12-year-old children had higher TNF-a levels regardless
of S. haematobium–infection status.
After adjusting for age, sex, location, and other variables,
children affected by malaria were younger (5–6 years old) and
had significantly higher IL-6 levels (Table 2) although those
co-infected with malaria and hookworm infection had relatively
lower IL-6 levels, suggesting a significant immunomodulation
between these two infections. Although IL-10 levels were
significantly higher in S. haematobium–infected children, they
were lower among those who had S. haematobium–filarial
co-infection (Table 3). There was overall a positive correla-
tion between IL-6 and TNF-a levels, and TNF-a and IL-10
levels, respectively.
Cytokine levels and morbidity outcomes. Morbidity status
measured as stunting (chronic malnutrition), wasting (acute
malnutrition), or anemia was not associated with significant
differences in measured circulating cytokines in our cross-
sectional survey. The exception was IL-10 levels that were
significantly elevated among wasted children.
DISCUSSION
Our results show an overall association between down-
regulatory IL-10 cytokine and S. haematobium infection, but
with relatively lower levels in early puberty (11–13 years old)
and late adolescence (17–19 years old). Contrary to what was
expected, circulating levels of pro-inflammatory cytokines
(IL-6 and TNF-a) were not associated with urogenital schisto-
somiasis, even though granulomatous inflammation with T-cell
activation is a hallmark of S. haematobium infection.3,15 Chil-
dren with malaria had a significant higher pro-inflammatory
IL-6 levels, particularly in the younger ones (5–7 years old),
although lower levels were seen in children co-infected with
both malaria and hookworm. Striking inter-village differences
were found for cytokine levels and morbidity outcomes, sug-
gesting a clustering effect possibly related to geographical
transmission patterns and nutritional and/or socioeconomic
disparities.16,17 This highlights the multi-dimensional approaches
needed to understand schistosomiasis infection and disease in
the context of other endemic parasitic infections,18 and the
social determinants of health that remain so far unexplored
in this field. The unforeseen lack of association between
schistosomiasis-associated morbidities (anemia, wasting, and
stunting) and pro-inflammatory cytokines previously seen in
other endemic settings5,18,19 might be explained by the intrinsic
plasma level variability of cytokine levels when compared
with laboratory responses seen in antigen T-cell-stimulating
assays performed in other studies.18–20 Co-infections could
have also played an important role. For example, interactions
across the immune responses to co-infecting parasites have
been suggested in studies in Mali, where immune responses
to acute malaria were blunted in children co-infected with
urogenital schistosomiasis whose baseline production of IL-6,
IL-4, IL-10, and interferon (INF)-g was initially high.21,22 In
subsequent acute malaria infection, among 4- to 8-year-olds,
the production of IL-6 was blunted in S. haematobium–positive
children compared with those who were S. haematobium nega-
tive, suggesting a relative protective effect of S. haematobium
co-infection on the outcomes of acute P. falciparum malaria.22
Age- or experience-related factors likely modify this interac-
tion. A smaller study in Senegal found increased production of
anti-fibrogenic INFg in S. haematobium–infected children who
had P. falciparum malaria.23 Increased levels of INFg, seen in
acute schistosomiasis24 have also been associated with protec-
tion against periportal fibrosis.25 The interesting inverse rela-
tionship between IL-6 and malaria–hookworm co-infection
found in this study could potentially have the same immune
mechanism as Plasmodium–Schistosoma, as hookworm and
Schistosoma share some common host-regulatory pathways.26
In intestinal schistosomiasis, IL-10 is believed to have anti-
inflammatory immunomodulatory effects as its greater pres-
ence is associated with reduced risk of periportal fibrosis from
either S. mansoni or S. japonicum infection.7,27 Therefore, our
findings of high IL-10 in children with urogenital schistosomi-
asis in mid-puberty suggest a possible acquired, age-related
protective effect against further morbidity following the 13-
to 14-year-old age mark.28 Protection against S. japonicum
re-infection has also been described in association with sex
hormone production during late puberty,29 and there may
well be a cytokine–hormone interplay contributing to this
effect. In the same geographical location as our study, a posi-
tive correlation has been found in adolescent males between
structural urinary tract pathology and the simultaneous pres-
ence of low levels of IL-10 and high levels of TNF-a in response
to S. haematobium antigens.18 Elevated pro-inflammatory
TNF-a is associated with hepatic fibrosis in a S. mansoni–
endemic area in Uganda and S. japonicum–endemic settings
in the Philippines and China.6,20,27 Parasite-induced inflam-
mation is thought to be part of the causal pathway of under-
nutrition and anemia.5,6,9 Our results, however, did not show
any association between IL-6 or TNF-a and the wasting,
stunting, or anemia in this group of children.
There are several limitations in our study. First, current
serum cytokine levels taken in cross section may not accu-
rately reflect the ongoing in vivo effects of infection related
to different antigenic stimulation. Single time point cytokine
detection in the circulation, rather than in the local tissue
microenvironments, is an inherent limitation to this kind of
Table 4
Multivariable log-linear modeling for the association of TNF-a with
potential explanatory variables
Variables
Multivariable model for log10-TNF-a level
B coefficient 95% CI P value
IL-10* 0.561 (0.343, 0.420) < 0.0001
IL-6* 0.176 (0.106, 0.207) < 0.0001
Sex (male) −0.038 (−0.081, 0.016) 0.149
Village (Vuga) −0.024 (−0.088, 0.039) 0.126
11–12 years old 0.135 (0.078, 0.244) < 0.0001
Wasted† −0.063 (−0.134, 0.009) 0.087
Stunted‡ 0.020 (−0.041, 0.077) 0.545
Malaria 0.026 (−0.038, 0.105) 0.356
S. haematobium§ 0.056 (−0.006, 0.105) 0.080
Hookworm −0.025 (−0.103, 0.040) 0.389
Final models adjusted for sex, age category, location, wasting, stunting, anemia, individual
infections (S. haematobium, malaria, hookworm), and significant interactions for infection by
two or more parasites.
* log10 of IL-10 and IL-6.
†Wasting: Body mass index-for-age Z score (BAZ) < −2 SD.
‡Stunting: Height-for-age Z score (HAZ) < −2 SD.
§Positive infection status is defined by S. haematobium egg +/antibody +, egg –/antibody +,
or egg +/antibody –.
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study. The study was a single cross section, and therefore
no post-treatment changes could be established to support
parasite-specific associations. The effect of treatment on cyto-
kine profile and its relationship to anemia and nutritional
morbidity reversal would be an important question to address
given that hepatic vascular remodeling has been shown to
occur after treatment in studies in animal models of schisto-
somiasis.20,30,31 Exploring other cytokines not included in this
study (i.e., IL-4, IL-5, and IL-13) and important in under-
standing the immune response to multiple parasitic infections
should be integrated in future research efforts.20
In summary, we have shown age-specific variation in serum
cytokine profiles among children with S. haematobium and
other chronic parasitic infections. The high levels of IL-10 in
young children with schistosomiasis could potentially protect
them against developing inflammation-related morbidity. Fur-
ther pairing of morbidity assessment studies with more refined
T-cell stimulation assays will help to strengthen assessments for
the appropriate timing of anti-schistosomal treatment for pre-
vention or remission of infection-related organ fibrosis.
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